These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21310976)

  • 1. Pharmaceuticals. Pfizer's shakeup means less money for research.
    Kean S
    Science; 2011 Feb; 331(6018):658. PubMed ID: 21310976
    [No Abstract]   [Full Text] [Related]  

  • 2. Pfizer's home remedy.
    Abkowitz A
    Fortune; 2009 Aug; 160(4):82-4, 86. PubMed ID: 19728588
    [No Abstract]   [Full Text] [Related]  

  • 3. Pfizer slashes R&D.
    Cressey D
    Nature; 2011 Feb; 470(7333):154. PubMed ID: 21307908
    [No Abstract]   [Full Text] [Related]  

  • 4. Recruiters and industry.
    Jackson M
    Nature; 2004 Mar; 428(6981):450. PubMed ID: 15042100
    [No Abstract]   [Full Text] [Related]  

  • 5. The 'apparent' color of money.
    Peritt D
    Nat Med; 2004 Feb; 10(2):120. PubMed ID: 14760411
    [No Abstract]   [Full Text] [Related]  

  • 6. The color of money.
    Ready T
    Nat Med; 2003 Nov; 9(11):1340-1. PubMed ID: 14595418
    [No Abstract]   [Full Text] [Related]  

  • 7. Florida welcomes Scripps as critics predict big-money flop.
    Dalton R
    Nature; 2003 Nov; 426(6962):4. PubMed ID: 14603275
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth industry.
    Lewis R
    Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202
    [No Abstract]   [Full Text] [Related]  

  • 9. Misleading congress about drug development: Reply.
    Dimasi JA; Hansen RW; Grabowski HG
    J Health Polit Policy Law; 2008 Apr; 33(2):319-24; discussion 325-7. PubMed ID: 18325904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portfolio analysis and R&D decision making.
    Evans R; Hinds S; Hammock D
    Nat Rev Drug Discov; 2009 Mar; 8(3):189-90. PubMed ID: 19182818
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug discovery veers off target.
    Shaffer C
    Drug Discov Today; 2005 Nov; 10(22):1489. PubMed ID: 16257367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
    Patel AC; Coyle AJ
    Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247
    [No Abstract]   [Full Text] [Related]  

  • 13. Pfizer's puzzle.
    Simons J
    Fortune; 2006 Apr; 153(7):152-4, 156. PubMed ID: 16649633
    [No Abstract]   [Full Text] [Related]  

  • 14. Peter Corr outlines Pfizer's approach to innovation, maximizing capabilities and delivering essential medicine. Interview by Steve Carney.
    Corr PB
    Drug Discov Today; 2005 Aug; 10(15):1017-20. PubMed ID: 16055016
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS vaccine duo.
    Nature; 2005 Jun; 435(7046):1159. PubMed ID: 15988492
    [No Abstract]   [Full Text] [Related]  

  • 16. Your money or your life.
    Westphal SP
    New Sci; 2002 Jul; 175(2351):28-33. PubMed ID: 12625339
    [No Abstract]   [Full Text] [Related]  

  • 17. Boston means business for drug companies.
    Mervis J
    Science; 2005 Jul; 309(5735):723. PubMed ID: 16051782
    [No Abstract]   [Full Text] [Related]  

  • 18. Industry and medicine: conflicting interests and the power of money.
    Popovsky MA; Garcia N
    Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomedical research. Bristol-Myers ends no-strings grants.
    Kaiser J
    Science; 2006 Jun; 312(5778):1289. PubMed ID: 16741080
    [No Abstract]   [Full Text] [Related]  

  • 20. Global health. Public-private partnerships proliferate.
    Cohen J
    Science; 2006 Jan; 311(5758):167. PubMed ID: 16410497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.